The Deal
Saturday, November 21, 
12:53 am

Entries tagged "healthcare"

What will be the next Big Pharma deal?

There's been quite a bit of M&A activity in the pharma world lately. What companies within the sector will likely be the next to be acquired?


Roll Call: 'Too Big to Fail' Must Die

Here are some must-reads to kick off your week.


Video: Louis Capital's van Batenburg on Pfizer-Wyeth obstacles

In this edition of Inside the Deal, Robbert van Batenburg, head of equity research for Louis Capital Markets, tells Suzanne Stevens that the stakes for both companies are high.


Sanofi chief thinks smaller

French drug firm Sanofi-Aventis SA probably won't make a massive acquisition to boost its flagging product pipeline.


Genentech clinical trial could push Roche offer higher

Genentech Inc. said Wednesday it might see final data from a key clinical trial in April, an earlier-than-expected milestone that could influence the firm's ongoing takeover dance with majority owner Roche Holding AG....


J.P. Morgan's Dimon on a biotech bailout

J.P. Morgan Chase & Co. chief executive Jamie Dimon gave the lunch speech Monday to attendees of his firm's annual healthcare conference. He spoke from written notes and often, it seemed, off the cuff -- he called for healthcare changes as broad as universal coverage and as specific as more bicycle lanes -- a refreshing change from the usual PowerPoint-driven smoothness of back-to-back-to-back corporate presentations. ...


No Avastin bump for Genentech

Swiss drug giant Roche Holding AG said Tuesday it's still committed to a "negotiated settlement" in its pursuit of Genentech Inc. The remark came from CEO Severin Schwan during the firm's quarterly earnings call. In July Roche bid $43.7 billion, or $89 a share, for the 44% it doesn't already own. Genentech's board said it was too low but left the door open to higher offers. ...


Nursing homes continue to reel in Connecticut

Another Connecticut nursing home has bitten the dust, thanks to a state crackdown. ...


Assisted-living retirement communities need help themselves

We keep hearing baby boomers have just started retiring, meaning a big burst in the population of seniors in need of services, such as special housing, is coming. ...


Will someone swallow Bristol-Myers?

Could Bristol-Myers Squibb Co. be entertaining a sale in the future? Sanford C. Bernstein & Co. LLC analyst Tim Anderson might answer "good chance" based on a note he recently wrote, according to a Reuters article. ...


Blackstone fields $2.2B bids for Groupe Vitalia

New York private equity firm the Blackstone Group LP is entertaining up to four bids for its portfolio company, French hospital chain Groupe Vitalia, which has received offers of roughly $2.2 billion.   ...


Blackstone to take Apria private for $1.6B

Home healthcare services provider Apria Healthcare Group Inc. said Thursday it would go private in a deal it valued at $1.6 billon with an affiliate of Blackstone Group LP. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "healthcare." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.